Luliconazole1% cream was approved in Japan in 2005 for the treatment of tinea infections,followed by approval in November 2013 by the US Food and Drug Administration for the treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms T.rubrum and E.floccosum,in patiebts 18 years of age and older.